Brefeldin A sensitivity and resistance in Schizosaccharomyces pombe. Isolation of multiple genes conferring resistance.
The fungal metabolite brefeldin A (BFA) causes the inhibition of protein secretion and the disruption of the structure and function of the Golgi complex in mammalian cells. Here we show that BFA has identical effects in the fission yeast Schizosaccharomyces pombe which normally contains a Golgi complex of stacked cisternae similar to the Golgi complexes in animal cells. After treatment with BFA, secretion was inhibited, Golgi complexes disappeared, and there was an accumulation of endoplasmic reticulum. These results indicate that the effects of BFA in fungi are very similar to those in mammalian cells and provide direct evidence for an effect of BFA on Golgi morphology in fungi. Five spontaneous BFA-resistant mutants were isolated. Genetic analysis showed that the mutations conferring BFA resistance were dominant and in two separate linkage groups. One of the BFA-resistant mutations was found to be allelic to crm1, a gene affecting chromatin structure. All BFA-resistant mutants overexpressed a 20-kDa protein, and the corresponding gene obr1 was isolated and sequenced. However, obr1 overexpression was not sufficient to confer BFA resistance. Plasmids capable of conferring BFA resistance to wild type cells were isolated from libraries constructed from the two BFA-resistant mutants. These plasmids contain six different genes capable of conferring resistance when present in high copy. One of these genes encoded the transcription factor pap1, a homolog of the mammalian AP1 protein. The overexpression of pap1 probably confers BFA resistance indirectly by inducing expression of one or more other proteins. The isolation of several genes conferring BFA resistance suggests several mechanisms are involved.
Turi
T G
TG
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510.
Webster
P
P
Rose
J K
JK
D000595:Amino Acid Sequence; D000935:Antifungal Agents / Q000494:pharmacology*; D020126:Brefeldin A; D003517:Cyclopentanes / Q000494:pharmacology*; D004352:Drug Resistance, Microbial / Q000235:genetics; D005656:Fungal Proteins / Q000235:genetics; D006056:Golgi Apparatus / Q000187:drug effects; D028884:Karyopherins; D008969:Molecular Sequence Data; D009154:Mutation; D000073718:Pancreatitis-Associated Proteins; D010641:Phenotype; D010957:Plasmids; D018160:Receptors, Cytoplasmic and Nuclear; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000235:genetics; D012568:Schizosaccharomyces / Q000187:drug effects* / Q000235:genetics; D017386:Sequence Homology, Amino Acid; D000097606:Exportin 1 Protein
D000935:Antifungal Agents; D020126:Brefeldin A; D003517:Cyclopentanes; D005656:Fungal Proteins; D028884:Karyopherins; D000073718:Pancreatitis-Associated Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D000097606:Exportin 1 Protein; C000612141:REG3A protein, human